Pharnext SA
PAR:ALPHA

Watchlist Manager
Pharnext SA Logo
Pharnext SA
PAR:ALPHA
Watchlist
Price: 0.0002 EUR
Market Cap: 1.2k EUR

Relative Value

There is not enough data to reliably calculate the relative value of ALPHA.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALPHA Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
61.7
Industry
8.2
Forward
0
vs History
vs Industry
Median 3Y
-0
Median 5Y
-154 808.4
Industry
24.2
Forward
-0
vs History
vs Industry
Median 3Y
-0
Median 5Y
-232 763
Industry
23
vs History
vs Industry
Median 3Y
-0
Median 5Y
-256 430.4
Industry
25.5
vs History
vs Industry
Median 3Y
-0
Median 5Y
-182 010.7
Industry
3.3
vs History
vs Industry
Median 3Y
161.6
Median 5Y
223.3
Industry
8.6
Forward
12.7
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.5
vs History
vs Industry
Median 3Y
-0.9
Median 5Y
-218 503.3
Industry
6.1
Forward
-1
vs History
vs Industry
Median 3Y
-0.9
Median 5Y
-213 953.8
Industry
6.6
Forward
-1
vs History
vs Industry
Median 3Y
-1
Median 5Y
-232 763.3
Industry
8.8
vs History
vs Industry
Median 3Y
-1
Median 5Y
-232 218.4
Industry
6.8
vs History
vs Industry
Median 3Y
-6.1
Median 5Y
-6.1
Industry
5.7

Multiples Across Competitors

ALPHA Competitors Multiples
Pharnext SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Pharnext SA
PAR:ALPHA
1.2k EUR 0 -0 -0.9 -0.9
IL
Can Fite Biopharma Ltd
TASE:CANF
159.5T ILS 58 140 362.9 -3 992 706 -3 918 066.9 -3 909 345.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 004 331.7 -161 617.5 -196 255.2 -194 015.7
US
Abbvie Inc
NYSE:ABBV
388.9B USD 6.5 165.6 16.1 22.8
US
Amgen Inc
NASDAQ:AMGN
175.1B USD 4.9 25 18.1 18.1
US
Gilead Sciences Inc
NASDAQ:GILD
152.3B USD 5.2 18.8 12.6 12.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117B USD 10 31.8 23.4 24.4
US
Epizyme Inc
F:EPE
94.1B EUR 2 071.8 -528.7 -575.7 -560.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.9B USD 5.7 17.7 16.9 19.1
AU
CSL Ltd
ASX:CSL
83.9B AUD 3.6 18.8 12.7 15.8
NL
argenx SE
XBRU:ARGX
42.5B EUR 13.8 32.3 55.6 57.1
P/S Multiple
Revenue Growth P/S to Growth
FR
Pharnext SA
PAR:ALPHA
Average P/S: 8 376 983.3
0
N/A N/A
IL
C
Can Fite Biopharma Ltd
TASE:CANF
58 140 362.9
140%
415 288.3
FR
Pharnext SCA
OTC:PNEXF
34 004 331.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.5
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.9
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
5.2
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10
10%
1
US
E
Epizyme Inc
F:EPE
2 071.8
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.7
6%
0.9
AU
CSL Ltd
ASX:CSL
3.6
5%
0.7
NL
argenx SE
XBRU:ARGX
13.8
49%
0.3
P/E Multiple
Earnings Growth PEG
FR
Pharnext SA
PAR:ALPHA
Average P/E: 44.3
Not Available
N/A N/A
IL
C
Can Fite Biopharma Ltd
TASE:CANF
Negative Multiple: -3 992 706 N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 617.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
165.6
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.8
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.8
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -528.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.7
10%
1.8
AU
CSL Ltd
ASX:CSL
18.8
11%
1.7
NL
argenx SE
XBRU:ARGX
32.3
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Pharnext SA
PAR:ALPHA
Average EV/EBITDA: 22.2
Negative Multiple: -0.9
N/A N/A
IL
C
Can Fite Biopharma Ltd
TASE:CANF
Negative Multiple: -3 918 066.9 N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -196 255.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.1
14%
1.1
US
Amgen Inc
NASDAQ:AMGN
18.1
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.6
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.4
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -575.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.9
11%
1.5
AU
CSL Ltd
ASX:CSL
12.7
8%
1.6
NL
argenx SE
XBRU:ARGX
55.6
810%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
Pharnext SA
PAR:ALPHA
Average EV/EBIT: 24.3
Negative Multiple: -0.9
N/A N/A
IL
C
Can Fite Biopharma Ltd
TASE:CANF
Negative Multiple: -3 909 345.4 N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 015.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.8
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.1
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.6
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.4
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -560.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.1
13%
1.5
AU
CSL Ltd
ASX:CSL
15.8
11%
1.4
NL
argenx SE
XBRU:ARGX
57.1
N/A N/A